Decreased lymphocyte 3H-paroxetine binding in obsessive-compulsive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Molecular Biology

Background:

• The pathophysiology of obsessive-compulsive disorder (OCD) is strongly linked to the serotonin (5-HT) system.
• Serotonin transporters (5-HTTs) are crucial in regulating neurotransmission and have been implicated in OCD.
• The presence of 5-HTTs in blood lymphocytes offers a potential accessible biomarker for neurological disorders.

Purpose of the Study:

• To investigate the density of serotonin transporters (5-HTTs) in blood lymphocytes of drug-free OCD patients.
• To compare 5-HTT binding in OCD patients with age- and sex-matched healthy controls.
• To explore the utility of lymphocyte 5-HTTs as a potential biomarker in OCD.

Main Methods:

• Blood lymphocytes were isolated from drug-free OCD patients and healthy controls.
• Specific binding of (3H)-paroxetine ((3H)-PAR) to lymphocyte membranes was quantified.
• Standardized protocols were employed for membrane preparation and radioligand binding assays.

Main Results:

• A statistically significant lower density of (3H)-PAR-binding sites was observed in the lymphocytes of OCD patients compared to controls.
• This finding indicates reduced serotonin transporter availability in the peripheral blood cells of individuals with OCD.
• The results align with previous observations of altered 5-HTT in platelets of OCD patients.

Conclusions:

• The study demonstrates reduced serotonin transporter density in lymphocytes of OCD patients, supporting peripheral biomarkers for the disorder.
• Lymphocytes, being nucleated cells, provide a valuable model for studying transporter regulation in OCD and other conditions.
• These findings open new avenues for understanding the neurobiological underpinnings of OCD and developing novel therapeutic strategies.